JPMorgan: Maintain Alibaba Health (00241) "overweight" rating with a target price of HK $10.7

Like
Comment
Favorite

JPMorgan: Maintain Alibaba Health (00241) "overweight" rating with a target price of HK $10.7

智通财经2020-02-10

Zhitong Finance APP learned that JPMorgan released a report saying that Alibaba Health (00241) recently announced the acquisition of the Tmall drug sales platform from its parent company Alibaba (09988). RMB, the total transaction consideration is 8.075 billion yuan, equivalent to approximately 0.76 times the valuation/total transaction volume of the platform. The bank added that it has a positive sense of the above-mentioned transactions, and said that the timing of injecting the drug business is good, which will help Alibaba Health develop an online prescription drug sales platform in the mainland and further strengthen Alibaba Health's position as the flagship platform of Alibaba's big health. It believes...

Web link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

No comments yet

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2010240500?lang=en_US&edition=fundamental","thumbnail":"https://static.tigerbbs.com/331014881ee5d50c3f903d427c33934b","is_english":false,"pubTime":"2020-02-10 12:02","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2010240500","market":"hk","top_or_hot":-1,"title":"JPMorgan: Maintain Alibaba Health (00241) \"overweight\" rating with a target price of HK $10.7","media":"智通财经","content":"<p><div>Zhitong Finance APP learned that JPMorgan released a report saying that Alibaba Health (00241) recently announced the acquisition of the Tmall drug sales platform from its parent company Alibaba (09988). RMB, the total transaction consideration is 8.075 billion yuan, equivalent to approximately 0.76 times the valuation/total transaction volume of the platform. The bank added that it has a positive sense of the above-mentioned transactions, and said that the timing of injecting the drug business is good, which will help Alibaba Health develop an online prescription drug sales platform in the mainland and further strengthen Alibaba Health's position as the flagship platform of Alibaba's big health. It believes...</p><p><a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2020021012110379a7cd18&s=b\">Web link</a></div></p>","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>JPMorgan: Maintain Alibaba Health (00241) \"overweight\" rating with a target price of HK $10.7</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJPMorgan: Maintain Alibaba Health (00241) \"overweight\" rating with a target price of HK $10.7\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">智通财经</strong><span class=\"h-time small\">2020-02-10 12:02</span>\n</p>\n</h4>\n</header>\n<article>\n<p><div>Zhitong Finance APP learned that JPMorgan released a report saying that Alibaba Health (00241) recently announced the acquisition of the Tmall drug sales platform from its parent company Alibaba (09988). RMB, the total transaction consideration is 8.075 billion yuan, equivalent to approximately 0.76 times the valuation/total transaction volume of the platform. The bank added that it has a positive sense of the above-mentioned transactions, and said that the timing of injecting the drug business is good, which will help Alibaba Health develop an online prescription drug sales platform in the mainland and further strengthen Alibaba Health's position as the flagship platform of Alibaba's big health. It believes...</p><p><a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2020021012110379a7cd18&s=b\">Web link</a></div></p>\n<div class=\"bt-text\">\n\n\n<p> source：<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2020021012110379a7cd18&s=b\">智通财经</a></p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"JPM","symbol_name":"摩根大通","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2020021012110379a7cd18&s=b","article_id":"2010240500","we_media_id":null,"thumbnails":["https://static.tigerbbs.com/331014881ee5d50c3f903d427c33934b"],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2020021012110379a7cd18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2010240500","pubTimestamp":1581307330,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"智通财经APP获悉，小摩发布报告称，阿里健康(00241)日前公布向母公司阿里巴巴(09988)收购天猫药品销售平台，目标业务于截至去年3月底止年度产生总交易金额约95.75亿元人民币，交易总对价80","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":["rate"],"viewcount":null,"language":"zh","relate_stocks":{"JPM":"摩根大通","00241":"阿里健康"},"translate_title":"Xiao Mo: Maintain Ali's Health (00241) \"Overweight\" Rating Target Price of HK $10.7","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00241":0.6,"JPM":0.6},"content_text":"智通财经APP获悉，小摩发布报告称，阿里健康(00241)日前公布向母公司阿里巴巴(09988)收购天猫药品销售平台，目标业务于截至去年3月底止年度产生总交易金额约95.75亿元人民币，交易总对价80.75亿元，相当于估值/平台总交易额约0.76倍。该行补充，对上述交易感正面，更称注入药物业务的时机佳，将有助阿里健康开拓内地网上处方药销售平台，更强化阿里健康作为阿里巴巴大健康旗舰平台的地位，相信短期内对阿里健康股价会有正面刺激作用。该行表示，维持其“增持”评级，目标价10.7港元。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}